MindMaze Therapeutics Holding (RLFTF)

[nelskof]

No, not at all. 102 patients is very small. Even 144 is small. Most therapeutics are running in the hundreds. Where vaccines are in the thousands.

I wouldn't be surprised in the least bit if the DMC and FDA said finish the trial, get more data and then we'll talk.

Javitt alluded in the video the FDA was bending any rules "at least not with us".

I need to go back and listen again later about the pharmacy being re-purposed to create the IV version. I guess they'll continue to do that? The inhaler is the partnership.